# PTC Therapeutics, Inc.: Form 8-K, filed Mar 25, 2026

- Company: [PTC Therapeutics, Inc.](/companies/ptct.md) (CIK 1070081)
- Form: 8-K
- Filed: 2026-03-25
- Accepted by EDGAR: Mar 25, 2026, 09:00 ET
- Period: 2026-03-24
- Accession: 0001104659-26-034207
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070081/000110465926034207/tmb-20260324x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070081/000110465926034207/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1070081/000110465926034207/tmb-20260324x8k.htm

Filed Mar 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-034207. Last ingested by Listed: Oct 29, 2026, 18:45 ET. No prices; not investment advice.